Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Novo Nordisk A/S - Status regarding Novo Nordisk's holding of its own shares
Yahoo/Globe NewsWire
Sat, 01/3/15 - 10:58 am
Novo Nordisk
Novo Nordisk to promote drug to treat obesity in United States
Yahoo/Reuters
Mon, 12/29/14 - 11:13 am
Novo Nordisk
obesity
Saxenda
Novo Nordisk CEO Speaks Of Short-Term Challenges That Could Limit Growth
Bidness Etc.
Mon, 12/29/14 - 11:03 am
Novo Nordisk
Pharma CEOs
insulin
Tresiba
Lars Sorenson
Novo Nordisk CEO sees short-term challenges to growth - paper
Yahoo/Reuters
Sat, 12/27/14 - 10:33 am
Novo Nordisk
4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Fri, 12/26/14 - 10:11 pm
Bristol-Myers Squibb
Opdivo
Merck
Cubist Pharmaceuticals
Zerbaxa
AstraZeneca
Lynparza
Novo Nordisk
Saxenda
FDA approves Novo Nordisk's Saxenda, an injectable weight-loss treatment
Yahoo/AP
Wed, 12/24/14 - 08:44 am
Novo Nordisk
FDA
Saxenda
obesity
liraglutide
Will Diabetes Drugs Enter The Anti-Obesity Space?
Seeking Alpha
Mon, 12/8/14 - 08:30 am
diabetes
obesity
Arena Pharmaceuticals
Novo Nordisk
AstraZeneca
Orexigen
Vivus
Farxiga
Victoza
Invokana
Diabetes: The Global Epidemic Pushing Novo Nordisk Higher
Seeking Alpha
Sat, 11/29/14 - 12:37 pm
diabetes
Novo Nordisk
Novo Nordisk's Victoza receives positive opinion for use in adults with type 2 diabetes
Reuters
Fri, 11/21/14 - 10:41 am
Novo Nordisk
type 2 diabetes
diabetes
Victoza
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thu, 11/6/14 - 09:03 am
Sovaldi
Gilead Sciences
Eyelea
Tecfidera
Zytiga
Kalydeco
Vertex Pharmaceuticals
Victoza
Novo Nordisk
Gilenya
Yervoy
Xtandi
Stribild
Stelara
Novo Nordisk builds blockbuster case with promising PhIII obesity data
Fierce Biotech
Tue, 11/4/14 - 10:39 am
Novo Nordisk
obesity
liraglutide
Novo Nordisk reassures on 2015 outlook after Sanofi jolt
Yahoo/Reuters
Thu, 10/30/14 - 09:23 am
Novo Nordisk
Sanofi
Tresiba
Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues
Bidness Etc.
Mon, 10/6/14 - 11:51 am
Sanofi
Novo Nordisk
basal insulin
diabetes
Lantus
Levemir
Novo Nordisk Establishes New Obesity Research Unit
Drug Discovery and Development
Mon, 09/29/14 - 06:40 pm
Novo Nordisk
obesity
R&D
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes
Yahoo/Zacks.com
Tue, 09/23/14 - 07:46 am
Novo Nordisk
Xultophy
diabetes
Tresiba
Victoza
Are obesity drugs nearing a breakout? Novo, Takeda think so
Fierce Pharma
Thu, 09/18/14 - 09:18 am
Novo Nordisk
Takeda
obesity
Saxenda
Sanofi Still Ahead Of Novo Nordisk In Insulin Drug Race
Bidness Etc.
Wed, 09/17/14 - 04:53 pm
Sanofi
Novo Nordisk
diabetes
insulin
Lantus
Tresiba
Toujeo
Novo May Add Hundreds to R&D Staff for Obesity Medicines
Bloomberg
Wed, 09/17/14 - 08:38 am
Novo Nordisk
R&D
hirings
Saxenda
obesity
Study shows Novo's new diabetes drug effective and safe for children
Yahoo/Reuters
Tue, 09/16/14 - 12:11 pm
Novo Nordisk
diabetes
pediatric
insulin
Tresiba
Big Pharma: $100 Billion In Future Sales Expected
Bidness Etc.
Mon, 09/15/14 - 10:10 am
Bristol-Myers Squibb
Merck
GSK
Novo Nordisk
Sanofi
Novartis
Pfizer
Biogen Idec
Roche
Pages
« first
‹ previous
…
35
36
37
38
39
40
41
42
43
…
next ›
last »